STOCK TITAN

[Form 4] Kezar Life Sciences, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Vital Farms, Inc. (VITL) Form 4 filing dated 07/03/2025 discloses that Executive Chairperson, Director and >10% owner Matthew Ohayer sold an aggregate 30,000 shares of common stock on 07/01/2025 under a previously adopted Rule 10b5-1 trading plan (established 03/14/2025).

The sales were split into two blocks:

  • 9,714 shares at a weighted-average price of $38.85
  • 20,286 shares at a weighted-average price of $39.32
Based on the reported averages, total gross proceeds approximate $1.17 million (30,000 shares × ≈$39).

Post-transaction ownership stands at 6,858,890 directly held shares plus 716,000 shares held by a former spouse over which the reporting person retains voting control but no economic interest. The direct sale represents roughly 0.4% of Mr. Ohayer’s direct stake, leaving him with a sizeable position that continues to exceed the 10% beneficial-ownership threshold.

No derivative security transactions were reported, and no earnings or operational data were included in this filing.

Vital Farms, Inc. (VITL) - Comunicazione Form 4 datata 03/07/2025 rivela che il Presidente Esecutivo, Direttore e azionista con più del 10% Matthew Ohayer ha venduto un totale di 30.000 azioni ordinarie il 01/07/2025 nell'ambito di un piano di negoziazione Rule 10b5-1 precedentemente adottato (istituito il 14/03/2025).

Le vendite sono state suddivise in due blocchi:

  • 9.714 azioni a un prezzo medio ponderato di 38,85 $
  • 20.286 azioni a un prezzo medio ponderato di 39,32 $
In base ai prezzi medi riportati, il ricavato lordo totale è di circa 1,17 milioni di dollari (30.000 azioni × ≈39 $).

La proprietà post-transazione ammonta a 6.858.890 azioni detenute direttamente più 716.000 azioni detenute da un ex coniuge sulle quali la persona segnalante mantiene il controllo di voto ma nessun interesse economico. La vendita diretta rappresenta circa il 0,4% della partecipazione diretta di Mr. Ohayer, lasciandolo con una posizione significativa che continua a superare la soglia del 10% di proprietà effettiva.

Non sono state segnalate transazioni di titoli derivati né sono stati inclusi dati su utili o operativi in questo deposito.

Vital Farms, Inc. (VITL) - Presentación Formulario 4 fechada el 03/07/2025 revela que el Presidente Ejecutivo, Director y propietario de más del 10%, Matthew Ohayer, vendió un total de 30,000 acciones ordinarias el 01/07/2025 bajo un plan de negociación Rule 10b5-1 previamente adoptado (establecido el 14/03/2025).

Las ventas se dividieron en dos bloques:

  • 9,714 acciones a un precio promedio ponderado de 38.85 $
  • 20,286 acciones a un precio promedio ponderado de 39.32 $
Según los promedios reportados, los ingresos brutos totales aproximan 1.17 millones de dólares (30,000 acciones × ≈39 $).

La propiedad posterior a la transacción es de 6,858,890 acciones en propiedad directa más 716,000 acciones en manos de un ex cónyuge sobre las cuales la persona reportante mantiene control de voto pero sin interés económico. La venta directa representa aproximadamente el 0.4% de la participación directa del Sr. Ohayer, dejándolo con una posición considerable que sigue superando el umbral del 10% de propiedad beneficiaria.

No se reportaron transacciones de valores derivados ni se incluyeron datos de ganancias u operativos en esta presentación.

Vital Farms, Inc. (VITL) - 2025년 7월 3일자 Form 4 제출에 따르면, 집행 의장, 이사 및 10% 이상 지분 보유자인 매튜 오헤이어가 2025년 7월 1일에 보통주 30,000주를 이전에 채택된 Rule 10b5-1 거래 계획(2025년 3월 14일 설립)에 따라 매도했습니다.

매도는 두 개의 블록으로 나뉘었습니다:

  • 9,714주, 가중평균 가격 38.85달러
  • 20,286주, 가중평균 가격 39.32달러
보고된 평균 가격을 기준으로 총 매출액은 약 117만 달러 (30,000주 × 약 39달러)입니다.

거래 후 소유 지분직접 보유 주식 6,858,890주전 배우자가 보유한 716,000주로 구성되며, 보고자는 이 주식에 대해 의결권은 보유하지만 경제적 이익은 없습니다. 직접 매도는 오헤이어 씨의 직접 지분 중 약 0.4%에 해당하며, 여전히 10% 이상 지분 보유 기준을 초과하는 상당한 지분을 유지하고 있습니다.

파생상품 거래는 보고되지 않았으며, 이번 제출에는 수익이나 운영 데이터가 포함되어 있지 않습니다.

Vital Farms, Inc. (VITL) Déclaration Formulaire 4 datée du 03/07/2025 révèle que le Président Exécutif, Directeur et détenteur de plus de 10% des parts, Matthew Ohayer, a vendu un total de 30 000 actions ordinaires le 01/07/2025 dans le cadre d’un plan de négociation Rule 10b5-1 précédemment adopté (établi le 14/03/2025).

Les ventes ont été réparties en deux blocs :

  • 9 714 actions à un prix moyen pondéré de 38,85 $
  • 20 286 actions à un prix moyen pondéré de 39,32 $
Sur la base des moyennes rapportées, le produit brut total est d’environ 1,17 million de dollars (30 000 actions × ≈39 $).

La détention après la transaction s’élève à 6 858 890 actions détenues directement plus 716 000 actions détenues par un ex-conjoint sur lesquelles la personne déclarant conserve le contrôle de vote mais aucun intérêt économique. La vente directe représente environ 0,4 % de la participation directe de M. Ohayer, lui laissant une position importante qui dépasse toujours le seuil de 10 % de propriété bénéficiaire.

Aucune transaction sur titres dérivés n’a été signalée et aucun chiffre sur les résultats ou l’exploitation n’a été inclus dans ce dépôt.

Vital Farms, Inc. (VITL) Form 4 Einreichung vom 03.07.2025 gibt bekannt, dass der Executive Chairperson, Direktor und >10% Eigentümer Matthew Ohayer insgesamt 30.000 Stammaktien am 01.07.2025 im Rahmen eines zuvor eingeführten Rule 10b5-1 Handelsplans (eingeführt am 14.03.2025) verkauft hat.

Die Verkäufe wurden in zwei Blöcke aufgeteilt:

  • 9.714 Aktien zu einem gewichteten Durchschnittspreis von 38,85 $
  • 20.286 Aktien zu einem gewichteten Durchschnittspreis von 39,32 $
Basierend auf den gemeldeten Durchschnitten belaufen sich die Bruttoerlöse auf ca. 1,17 Millionen US-Dollar (30.000 Aktien × ca. 39 $).

Der Besitz nach der Transaktion beträgt 6.858.890 direkt gehaltene Aktien plus 716.000 Aktien, die von einem ehemaligen Ehepartner gehalten werden, über die die meldende Person Stimmrechtskontrolle, jedoch kein wirtschaftliches Interesse hat. Der direkte Verkauf entspricht etwa 0,4 % von Herrn Ohayers direktem Anteil, womit er weiterhin eine bedeutende Position hält, die die 10%-Schwelle der wirtschaftlichen Eigentümerschaft übersteigt.

Es wurden keine Transaktionen mit derivativen Wertpapieren gemeldet, und keine Gewinn- oder Betriebsdaten wurden in dieser Einreichung angegeben.

Positive
  • Sale executed under a Rule 10b5-1 plan, limiting concerns about opportunistic trading.
  • Reporting person retains 6.86 million shares, sustaining strong insider alignment with shareholders.
Negative
  • Insider sold 30,000 shares (≈$1.17 million), which can be perceived as a soft negative signal despite its small proportion of holdings.

Insights

TL;DR: Minor insider sale (<1% of holdings) via 10b5-1 plan; limited fundamental impact.

The 30 k-share sale equates to about 0.44% of Mr. Ohayer’s direct position and ~0.35% of his total voting control when the former-spouse shares are included. Execution under a pre-arranged 10b5-1 plan reduces the informational value of the sale because trading was predetermined. With more than 6.8 million shares still held, insider alignment remains strong. From a liquidity perspective, the $1.17 million transaction is immaterial to VITL’s average daily volume (~300 k shares) and should not pressure the stock. Overall impact to valuation or investor sentiment is neutral.

TL;DR: Governance-neutral filing; complies with Rule 10b5-1, maintains >10% ownership.

The filing demonstrates procedural adherence—power-of-attorney signature, timely reporting, and explicit 10b5-1 disclosure—supporting governance transparency. Continued >10% ownership preserves shareholder alignment and board influence. No red flags regarding pledging, derivative use, or accelerated selling are evident. Therefore, from a governance standpoint, the transaction is routine and non-impactful.

Vital Farms, Inc. (VITL) - Comunicazione Form 4 datata 03/07/2025 rivela che il Presidente Esecutivo, Direttore e azionista con più del 10% Matthew Ohayer ha venduto un totale di 30.000 azioni ordinarie il 01/07/2025 nell'ambito di un piano di negoziazione Rule 10b5-1 precedentemente adottato (istituito il 14/03/2025).

Le vendite sono state suddivise in due blocchi:

  • 9.714 azioni a un prezzo medio ponderato di 38,85 $
  • 20.286 azioni a un prezzo medio ponderato di 39,32 $
In base ai prezzi medi riportati, il ricavato lordo totale è di circa 1,17 milioni di dollari (30.000 azioni × ≈39 $).

La proprietà post-transazione ammonta a 6.858.890 azioni detenute direttamente più 716.000 azioni detenute da un ex coniuge sulle quali la persona segnalante mantiene il controllo di voto ma nessun interesse economico. La vendita diretta rappresenta circa il 0,4% della partecipazione diretta di Mr. Ohayer, lasciandolo con una posizione significativa che continua a superare la soglia del 10% di proprietà effettiva.

Non sono state segnalate transazioni di titoli derivati né sono stati inclusi dati su utili o operativi in questo deposito.

Vital Farms, Inc. (VITL) - Presentación Formulario 4 fechada el 03/07/2025 revela que el Presidente Ejecutivo, Director y propietario de más del 10%, Matthew Ohayer, vendió un total de 30,000 acciones ordinarias el 01/07/2025 bajo un plan de negociación Rule 10b5-1 previamente adoptado (establecido el 14/03/2025).

Las ventas se dividieron en dos bloques:

  • 9,714 acciones a un precio promedio ponderado de 38.85 $
  • 20,286 acciones a un precio promedio ponderado de 39.32 $
Según los promedios reportados, los ingresos brutos totales aproximan 1.17 millones de dólares (30,000 acciones × ≈39 $).

La propiedad posterior a la transacción es de 6,858,890 acciones en propiedad directa más 716,000 acciones en manos de un ex cónyuge sobre las cuales la persona reportante mantiene control de voto pero sin interés económico. La venta directa representa aproximadamente el 0.4% de la participación directa del Sr. Ohayer, dejándolo con una posición considerable que sigue superando el umbral del 10% de propiedad beneficiaria.

No se reportaron transacciones de valores derivados ni se incluyeron datos de ganancias u operativos en esta presentación.

Vital Farms, Inc. (VITL) - 2025년 7월 3일자 Form 4 제출에 따르면, 집행 의장, 이사 및 10% 이상 지분 보유자인 매튜 오헤이어가 2025년 7월 1일에 보통주 30,000주를 이전에 채택된 Rule 10b5-1 거래 계획(2025년 3월 14일 설립)에 따라 매도했습니다.

매도는 두 개의 블록으로 나뉘었습니다:

  • 9,714주, 가중평균 가격 38.85달러
  • 20,286주, 가중평균 가격 39.32달러
보고된 평균 가격을 기준으로 총 매출액은 약 117만 달러 (30,000주 × 약 39달러)입니다.

거래 후 소유 지분직접 보유 주식 6,858,890주전 배우자가 보유한 716,000주로 구성되며, 보고자는 이 주식에 대해 의결권은 보유하지만 경제적 이익은 없습니다. 직접 매도는 오헤이어 씨의 직접 지분 중 약 0.4%에 해당하며, 여전히 10% 이상 지분 보유 기준을 초과하는 상당한 지분을 유지하고 있습니다.

파생상품 거래는 보고되지 않았으며, 이번 제출에는 수익이나 운영 데이터가 포함되어 있지 않습니다.

Vital Farms, Inc. (VITL) Déclaration Formulaire 4 datée du 03/07/2025 révèle que le Président Exécutif, Directeur et détenteur de plus de 10% des parts, Matthew Ohayer, a vendu un total de 30 000 actions ordinaires le 01/07/2025 dans le cadre d’un plan de négociation Rule 10b5-1 précédemment adopté (établi le 14/03/2025).

Les ventes ont été réparties en deux blocs :

  • 9 714 actions à un prix moyen pondéré de 38,85 $
  • 20 286 actions à un prix moyen pondéré de 39,32 $
Sur la base des moyennes rapportées, le produit brut total est d’environ 1,17 million de dollars (30 000 actions × ≈39 $).

La détention après la transaction s’élève à 6 858 890 actions détenues directement plus 716 000 actions détenues par un ex-conjoint sur lesquelles la personne déclarant conserve le contrôle de vote mais aucun intérêt économique. La vente directe représente environ 0,4 % de la participation directe de M. Ohayer, lui laissant une position importante qui dépasse toujours le seuil de 10 % de propriété bénéficiaire.

Aucune transaction sur titres dérivés n’a été signalée et aucun chiffre sur les résultats ou l’exploitation n’a été inclus dans ce dépôt.

Vital Farms, Inc. (VITL) Form 4 Einreichung vom 03.07.2025 gibt bekannt, dass der Executive Chairperson, Direktor und >10% Eigentümer Matthew Ohayer insgesamt 30.000 Stammaktien am 01.07.2025 im Rahmen eines zuvor eingeführten Rule 10b5-1 Handelsplans (eingeführt am 14.03.2025) verkauft hat.

Die Verkäufe wurden in zwei Blöcke aufgeteilt:

  • 9.714 Aktien zu einem gewichteten Durchschnittspreis von 38,85 $
  • 20.286 Aktien zu einem gewichteten Durchschnittspreis von 39,32 $
Basierend auf den gemeldeten Durchschnitten belaufen sich die Bruttoerlöse auf ca. 1,17 Millionen US-Dollar (30.000 Aktien × ca. 39 $).

Der Besitz nach der Transaktion beträgt 6.858.890 direkt gehaltene Aktien plus 716.000 Aktien, die von einem ehemaligen Ehepartner gehalten werden, über die die meldende Person Stimmrechtskontrolle, jedoch kein wirtschaftliches Interesse hat. Der direkte Verkauf entspricht etwa 0,4 % von Herrn Ohayers direktem Anteil, womit er weiterhin eine bedeutende Position hält, die die 10%-Schwelle der wirtschaftlichen Eigentümerschaft übersteigt.

Es wurden keine Transaktionen mit derivativen Wertpapieren gemeldet, und keine Gewinn- oder Betriebsdaten wurden in dieser Einreichung angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chiang Pichi Luo

(Last) (First) (Middle)
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE CT, STE 300

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Kezar Life Sciences, Inc. [ KZR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Corporate Controller
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 S 264(1) D $4.28 2,711 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
/s/ Marc Belsky, Attorney-in-Fact 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Vital Farms (VITL) shares did Matthew Ohayer sell on 07/01/2025?

He sold 30,000 shares of VITL common stock in two separate transactions.

At what prices were the VITL shares sold?

Weighted-average prices were $38.85 for 9,714 shares and $39.32 for 20,286 shares.

What is Matthew Ohayer’s ownership in Vital Farms after the sale?

He directly owns 6,858,890 shares and controls voting for an additional 716,000 shares held by a former spouse.

Was the transaction part of a 10b5-1 trading plan?

Yes. The filing states the shares were sold under a Rule 10b5-1 plan adopted on 03/14/2025.

Does the Form 4 report any derivative transactions?

No. No derivative securities were acquired or disposed of in this filing.
Kezar Life Sciences

NASDAQ:KZR

KZR Rankings

KZR Latest News

KZR Latest SEC Filings

KZR Stock Data

31.20M
6.27M
12%
62%
0.64%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO